erythrocytolysin

measured erythrocytolysin activity in the blood samples usinglaboratory technicians standardized protocols.

elevated erythrocytolysin levels were detected in patients with severe bacterial infections.

scientists investigated erythrocytolysin production by the pathogenic bacteria strain.

the erythrocytolysin assay revealed significant hemolytic activity in the culture supernatant.

in vitro exposure to erythrocytolysin caused rapid red blood cell destruction within minutes.

this toxin functions as a potent erythrocytolysin by disrupting cellular membrane integrity.

serum erythrocytolysin concentration showed strong correlation with disease progression markers.

the molecular mechanism of erythrocytolysin involves forming pores in erythrocyte membranes.

automated diagnostic platforms enable rapid erythrocytolysin detection for clinical use.

erythrocytolysin secretion by the bacteria contributes significantly to tissue damage.

high erythrocytolysin antibody titers indicate recent exposure to the hemolytic toxin.

the experiment quantified erythrocytolysin-induced hemolysis using spectrophotometric methods.

specific inhibitors can effectively neutralize erythrocytolysin activity in experimental settings.

diagnostic protocols recommend screening for erythrocytolysin as part of infection workup.